İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2023

The association of HLA-DRB1 alleles and MBL2 gene variant in pediatric acute lymphoblastic leukemia patients

Hematology, Transfusion and Cell Therapy

YÖKSİS OpenAlex ISSN 2531-1379 DOI 10.1016/j.htct.2023.02.002 Atıf 3 Açık erişim · diamond SJR Q3 JCR Q3

10.1016/j.htct.2023.02.002

YÖKSİS YÖKSİS makale kaydı

OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

OpenAlex kaydı

İngilizce (OpenAlex)

INTRODUCTION: Epidemiologic studies on pediatric acute lymphoblastic leukemias (ALL) have been conducted to evaluate the possible risk factors including genetic, infectious and environmental factors with the objective of idenfying the etiology. Mannose-binding lectin 2 (MBL2) plays an important role in first-line immune defense. HLA DRB1 alleles play a role in presentation of peptides to T cells and in activation of the adaptive immune response. OBJECTIVE: In our study, we aimed to investigate both the MBL2 gene variant and HLA-DRB1 alleles in pediatric ALL patients. MATERIALS: In this study, 86 high-risk ALL patients and 100 controls were included. Polymerase Chain Reaction (PCR)-Restriction Fragment Length Polymorphism (PCR-RFLP) and PCR-sequence specific primer (SSP) methods were used for detection of polymorphism of the MBL2 and HLA-DRB1 alleles, respectively. RESULTS: The frequency of the MBL2 AB genotype was lower in female ALL patients, compared to male ALL patients (p = 0.034). An association was found between the MBL2 BB genotype and DRB1*07 and among patients with the MBL2 BB genotype; those who also carried the DRB1*07 and *04 alleles were significantly higher than those without the DRB1*07 and *04 alleles. (p = 0.048, p = 0.022, respectively). CONCLUSION: This is the first study suggesting that the MBL2 BB genotype in association with the DRB1*07 or co-inheritance of the HLA-DRB1*04 and HLA DRB1*07 may have an impact on the etiopathogenesis of the disease.

OpenAlex zenginleştirmesi

Konular

  • Complement system in diseases
  • vaccines and immunoinformatics approaches
  • Immunotherapy and Immune Responses

Tür: article Complement system in diseases

İndeks bilgisi

WoS (JCR) ve Scopus (SJR) çeyrekleri ISSN ve yayın yılına göre. · 2023

Scopus (SJR) / WoS (JCR)

Hematology, Transfusion and Cell Therapy

Scopus (SJR) Q3 0,376 2023 yılı
WoS (JCR) Q3 JIF 1,8 2023 yılı

Üniversiteler

  • İSTANBUL MEDİPOL ÜNİVERSİTESİ

Yazarlar

  1. SÜLEYMAN RÜŞTÜ OĞUZ
  2. HAYRİYE ŞENTÜRK ÇİFTÇİ
  3. MÜGE GÜNDOĞDU
  4. YELİZ ÖĞRET
  5. SEDAT KARADENİZ
  6. SACİDE PEHLİVAN
  7. KÜRŞAT ÖZDİLLİ İSTANBUL MEDİPOL ÜNİVERSİTESİ
  8. ZEYNEP KARAKAŞ
  9. SERAP KARAMAN
  10. FİLİZ AYDIN